Atea Pharmaceuticals (AVIR) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.53
-0.45
-0.37
-0.29

Details

Expected EPS
-0.415
Actual EPS
-0.53
Surprise EPS
-0.12
Surprise Percent
+27.71%

Description

Atea Pharmaceuticals (AVIR) has reported earnings of -0.53 per share for Q4 2025.

0 Comments

Share your thoughts